VANGUARD GROUP INC 13D and 13G filings for X4 Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-01-31 10:09 am Sale |
2024-12-31 | 13G | X4 Pharmaceuticals, Inc. XFOR |
VANGUARD GROUP INC | 8,200,903 4.800% |
-239,827 (-2.84%) |
Filing |
| 2024-11-12 5:59 pm Unchanged |
2024-09-30 | 13G | X4 Pharmaceuticals, Inc. XFOR |
VANGUARD GROUP INC | 8,440,730 5.000% |
0 (Unchanged) |
Filing |
| 2024-11-04 2:15 pm Purchase |
2024-09-30 | 13G | X4 Pharmaceuticals, Inc. XFOR |
VANGUARD GROUP INC | 8,440,730 5.000% |
8,440,730 (New Position) |
Filing |